MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors.
Mor Zaaroor LevyNoa RabinowiczMaia Yamila KohonAvshalom ShalomAriel BerlTzipi Hornik-LurieLiat DruckerShelly Tartakover MatalonYair LevyPublished in: Biomedicines (2022)
miR-26 and miR-let-7d may be serological markers for SSc-PAH. The results of our study suggest their involvement in myofibroblast differentiation and complement pathway activation, both of which are active in PAH development.